Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMST01020027 | CE(15:0) | Lipid-depleted/compactin | 0.0 | BCD100427B02 | - | pmol/sample |
| LMST01020027 | CE(15:0) | Lipid-depleted/compactin | 0.5 | BCD100427B05 | 1.16 | pmol/sample |
| LMST01020027 | CE(15:0) | Lipid-depleted/compactin | 1.0 | BCD100427B09 | - | pmol/sample |
| LMST01020027 | CE(15:0) | Lipid-depleted/compactin | 2.0 | BCD100427B13 | - | pmol/sample |
| LMST01020027 | CE(15:0) | Lipid-depleted/compactin | 4.0 | BCD100427B17 | 1.06 | pmol/sample |
| LMST01020027 | CE(15:0) | Lipid-depleted/compactin | 8.0 | BCD100427B21 | - | pmol/sample |
| LMST01020027 | CE(15:0) | Lipid-depleted/compactin | 12.0 | BCD100427B25 | - | pmol/sample |
| LMST01020027 | CE(15:0) | Lipid-depleted/compactin | 24.0 | BCD100427B29 | - | pmol/sample |
| LMST01020027 | CE(15:0) | C | 0.0 | BCD100427B01 | 2.35 | pmol/sample |
| LMST01020027 | CE(15:0) | C | 0.5 | BCD100427B03 | 2.41 | pmol/sample |
| LMST01020027 | CE(15:0) | C | 1.0 | BCD100427B07 | 5.01 | pmol/sample |
| LMST01020027 | CE(15:0) | C | 2.0 | BCD100427B11 | 2.95 | pmol/sample |
| LMST01020027 | CE(15:0) | C | 4.0 | BCD100427B15 | 2.35 | pmol/sample |
| LMST01020027 | CE(15:0) | C | 8.0 | BCD100427B19 | 3 | pmol/sample |
| LMST01020027 | CE(15:0) | C | 12.0 | BCD100427B23 | 19.4 | pmol/sample |
| LMST01020027 | CE(15:0) | C | 24.0 | BCD100427B27 | 2.51 | pmol/sample |
| LMST01020027 | CE(15:0) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B06 | 1.17 | pmol/sample |
| LMST01020027 | CE(15:0) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B10 | - | pmol/sample |
| LMST01020027 | CE(15:0) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B14 | 1.17 | pmol/sample |
| LMST01020027 | CE(15:0) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B18 | 1.92 | pmol/sample |
| LMST01020027 | CE(15:0) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B22 | 4.55 | pmol/sample |
| LMST01020027 | CE(15:0) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B26 | 4.03 | pmol/sample |
| LMST01020027 | CE(15:0) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B30 | 4.33 | pmol/sample |
| LMST01020027 | CE(15:0) | 25OH-Chol | 0.5 | BCD100427B04 | 4.59 | pmol/sample |
| LMST01020027 | CE(15:0) | 25OH-Chol | 1.0 | BCD100427B08 | 3.15 | pmol/sample |
| LMST01020027 | CE(15:0) | 25OH-Chol | 2.0 | BCD100427B12 | 5.83 | pmol/sample |
| LMST01020027 | CE(15:0) | 25OH-Chol | 4.0 | BCD100427B16 | 3.46 | pmol/sample |
| LMST01020027 | CE(15:0) | 25OH-Chol | 8.0 | BCD100427B20 | 7 | pmol/sample |
| LMST01020027 | CE(15:0) | 25OH-Chol | 12.0 | BCD100427B24 | 6.4 | pmol/sample |
| LMST01020027 | CE(15:0) | 25OH-Chol | 24.0 | BCD100427B28 | 2.71 | pmol/sample |